Raily Aesthetic Medicine International Holdings (HKSE:02135) Interest Expense : HK$-3.1 Mil (TTM As of Jun. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Raily Aesthetic Medicine International Holdings Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Raily Aesthetic Medicine International Holdings's interest expense for the six months ended in Jun. 2023 was HK$ -1.4 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2023 was HK$-3.1 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Raily Aesthetic Medicine International Holdings's Operating Income for the six months ended in Jun. 2023 was HK$ -2.5 Mil. Raily Aesthetic Medicine International Holdings's Interest Expense for the six months ended in Jun. 2023 was HK$ -1.4 Mil. Raily Aesthetic Medicine International Holdings did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Raily Aesthetic Medicine International Holdings Interest Expense Historical Data

The historical data trend for Raily Aesthetic Medicine International Holdings's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Raily Aesthetic Medicine International Holdings Interest Expense Chart

Raily Aesthetic Medicine International Holdings Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-2.60

-2.90

-2.96

-3.13

-3.06

Raily Aesthetic Medicine International Holdings Semi-Annual Data
	Dec17	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Interest Expense	Get a 7-Day Free Trial							-1.65	-1.89	-1.33	-1.43	-1.63

Raily Aesthetic Medicine International Holdings Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-3.1 Mil.

Raily Aesthetic Medicine International Holdings (HKSE:02135) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Raily Aesthetic Medicine International Holdings's Interest Expense for the six months ended in Jun. 2023 was HK$-1.4 Mil. Its Operating Income for the six months ended in Jun. 2023 was HK$-2.5 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Jun. 2023 was HK$35.5 Mil.

Raily Aesthetic Medicine International Holdings's Interest Coverage for the quarter that ended in Jun. 2023 is calculated as

Raily Aesthetic Medicine International Holdings did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Raily Aesthetic Medicine International Holdings (HKSE:02135) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Raily Aesthetic Medicine International Holdings Ltd (HKSE:02135) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 290 North Zhongshan Road, 3-5th Floor, Minhang Tower, Gongshu District, Hangzhou, CHN

Website

http://m.raily.com

Raily Aesthetic Medicine International Holdings Ltd is an aesthetic medical service provider in Zhejiang Province, the PRC. It offers a broad range of aesthetic medical services to clients to meet their different aesthetic and anti-aging objectives. The group is organized into business units based on their services and has three reportable operating segments namely Aesthetic medical services which comprise principally inpatient services including surgical services and outpatient services including injection service, dermatology services, and others; and Consulting service segment which comprise principally management consulting services. Aesthetic medical equipment products comprise principally sales of surgical implants and aesthetic medical skincare products.

Executives

Fu Haishu	2201 Interest of corporation controlled by you
Jin Chunmiao	2202 Interest of your spouse
Ruide Consultation Limited	2101 Beneficial owner
Youxin Management Co., Limited	2101 Beneficial owner
Beauty Milkway (hk) Limited
China Orient Asset Management (international) Holding Limited
China Orient Asset Management Co., Ltd.
Dong Yin Development (holdings) Limited
Wise Leader Assets Ltd.
Shang Hai Dong Hua Jian Kang Guan Li He Huo Qi Ye You Xian He Huo
Dong Fang Zi Chan Guan Li Zhong Guo Kong Gu You Xian Gong Si
Shen Zhen Dong Fang Chuang Ye Tou Zi You Xian Gong Si
Shen Zhen Qian Hai Cai Fu Dong Fang Gu Quan Tou Zi Ji Jin Guan Li You Xian Gong Si
Qing Hai Sheng Dong Fang Cang Yi Yao Chan Ye Fa Zhan Ji Jin You Xian He Huo
Qing Hai Sheng Dong Fang Cang Yi Yao Chan Ye Tou Zi Guan Li You Xian Gong Si

Raily Aesthetic Medicine International Holdings (HKSE:02135) Headlines

No Headlines